Perfluoroether Peptide-Modified Artificial Viral Capsid for Enhanced Doxorubicin Delivery to Liver Cancer Cells
Hepatocellular carcinoma is difficult to treat owing to poor tumor selectivity, rapid hepatic clearance, intrinsic drug resistance, and the high susceptibility of healthy liver tissue to off-target toxicity. Although doxorubicin (Dox) is a potent and widely used chemotherapeutic agent, its application in liver cancer i...